9-136370636-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_052813.5(CARD9):​c.693G>A​(p.Thr231Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0342 in 1,612,742 control chromosomes in the GnomAD database, including 1,132 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.040 ( 141 hom., cov: 34)
Exomes 𝑓: 0.034 ( 991 hom. )

Consequence

CARD9
NM_052813.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.04

Publications

23 publications found
Variant links:
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]
CARD9 Gene-Disease associations (from GenCC):
  • deep dermatophytosis
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • predisposition to invasive fungal disease due to CARD9 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 9-136370636-C-T is Benign according to our data. Variant chr9-136370636-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 365848.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.04 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0899 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD9NM_052813.5 linkc.693G>A p.Thr231Thr synonymous_variant Exon 5 of 13 ENST00000371732.10 NP_434700.2
CARD9NM_052814.4 linkc.693G>A p.Thr231Thr synonymous_variant Exon 5 of 13 NP_434701.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD9ENST00000371732.10 linkc.693G>A p.Thr231Thr synonymous_variant Exon 5 of 13 1 NM_052813.5 ENSP00000360797.5
ENSG00000289701ENST00000696169.1 linkn.693G>A non_coding_transcript_exon_variant Exon 5 of 13 ENSP00000512460.1

Frequencies

GnomAD3 genomes
AF:
0.0398
AC:
6055
AN:
152232
Hom.:
140
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0500
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.0163
Gnomad ASJ
AF:
0.0288
Gnomad EAS
AF:
0.0973
Gnomad SAS
AF:
0.0532
Gnomad FIN
AF:
0.0454
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0336
Gnomad OTH
AF:
0.0306
GnomAD2 exomes
AF:
0.0386
AC:
9617
AN:
249382
AF XY:
0.0383
show subpopulations
Gnomad AFR exome
AF:
0.0523
Gnomad AMR exome
AF:
0.0122
Gnomad ASJ exome
AF:
0.0327
Gnomad EAS exome
AF:
0.100
Gnomad FIN exome
AF:
0.0439
Gnomad NFE exome
AF:
0.0337
Gnomad OTH exome
AF:
0.0341
GnomAD4 exome
AF:
0.0336
AC:
49133
AN:
1460392
Hom.:
991
Cov.:
33
AF XY:
0.0339
AC XY:
24600
AN XY:
726488
show subpopulations
African (AFR)
AF:
0.0492
AC:
1646
AN:
33474
American (AMR)
AF:
0.0124
AC:
556
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0302
AC:
790
AN:
26122
East Asian (EAS)
AF:
0.0832
AC:
3303
AN:
39688
South Asian (SAS)
AF:
0.0399
AC:
3441
AN:
86256
European-Finnish (FIN)
AF:
0.0455
AC:
2373
AN:
52116
Middle Eastern (MID)
AF:
0.00936
AC:
54
AN:
5768
European-Non Finnish (NFE)
AF:
0.0313
AC:
34757
AN:
1111880
Other (OTH)
AF:
0.0367
AC:
2213
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
3913
7826
11739
15652
19565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1310
2620
3930
5240
6550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0398
AC:
6065
AN:
152350
Hom.:
141
Cov.:
34
AF XY:
0.0400
AC XY:
2980
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0501
AC:
2085
AN:
41586
American (AMR)
AF:
0.0162
AC:
248
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
100
AN:
3468
East Asian (EAS)
AF:
0.0969
AC:
502
AN:
5178
South Asian (SAS)
AF:
0.0526
AC:
254
AN:
4830
European-Finnish (FIN)
AF:
0.0454
AC:
483
AN:
10632
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0336
AC:
2289
AN:
68024
Other (OTH)
AF:
0.0322
AC:
68
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
311
622
932
1243
1554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0370
Hom.:
54
Bravo
AF:
0.0370
Asia WGS
AF:
0.0950
AC:
331
AN:
3478
EpiCase
AF:
0.0302
EpiControl
AF:
0.0290

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Predisposition to invasive fungal disease due to CARD9 deficiency Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
0.85
DANN
Benign
0.87
PhyloP100
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59902911; hg19: chr9-139265088; COSMIC: COSV53733487; COSMIC: COSV53733487; API